PEG-MGF (Pegylated MGF) record · updated 20h ago

Muscle & body compMetabolic & appetiteGrade B · human evidenceResearch use only

All 1 studies Jump to the evidence Compare

What is PEG-MGF (Pegylated MGF) used for?

Pegylated Mechano Growth Factor | IGF-1 Splice Variant

How it works: promotes muscle growth and repair by stimulating satellite cell activation and proliferation

Primarily researched for · Muscle & body comp

Development stage

where PEG-MGF (Pegylated MGF) sits between preclinical work and regulatory approval

1Current
Preclinical
Animal / in-vitro work
2Not reached
Phase 1
Safety in humans
3Not reached
Phase 2
Efficacy signal
4Not reached
Phase 3
Confirmatory trials
5Not reached
Approved
Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 8 registered trials. It describes the research record, not a recommendation.

Identity

NamePEG-MGF (Pegylated MGF)

Chain length—

Molecular weight—

Formula—

Structure type—

ClassMuscle

Research levelLimited Research

Discovered byCurated master list · 2026

Pharmacology

Mechanismpromotes muscle growth and repair by stimulating satellite cell activation and proliferation

Route—

Half-life—

Time to peak—

Duration—

Extraction confidence0.70

Effect profile · 0–5

These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 12, 2026. How this works →

Research stats

Total studies1

Human / animal / cellular1 / 0 / 0

Highest trial phasePreclinical

Years covered2026

Latest study13d ago

Publication history

20262026

Research funding

—no NIH grants found

Safety signals

FAERS reportsnone recorded

Serious AEs in animal work—

Community reports—

Positive —Neutral —Negative —

Records

ChEMBL ClinicalTrials.gov DrugBank Google Scholar PubChem PubMed · 1 Semantic Scholar UniProt

Study register

1 rowOpen in the library →

Study	Type	Year	Summary depth
Whole-population trends in obesity across dimensions of inequality in England, 2019-25: a retrospective, longitudinal cohort study of 54 million adults. Finding22 per 1000 person-years overall age- and sex-standardised incidence of first-recorded obesity, 95% CI 22-22.	Human	2026	Full text read0.90

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching PEG-MGF (Pegylated MGF) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much PEG-MGF (Pegylated MGF) is discussed should be drawn from it.